期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
加味补肺汤联合莫沙西星治疗老年性肺炎疗效观察 被引量:4
1
作者 田亚楠 《实用中医药杂志》 2018年第12期1474-1475,共2页
目的:观察加味补肺汤联合莫沙西星治疗老年性肺炎的疗效。方法:76例随机分为两组各38例。两组均给予莫西沙星治疗,观察组加用加味补肺汤治疗,比较两组临床疗效、症状体征恢复时间及用药安全性。结果:总有效率观察组高于对照组(P<0.0... 目的:观察加味补肺汤联合莫沙西星治疗老年性肺炎的疗效。方法:76例随机分为两组各38例。两组均给予莫西沙星治疗,观察组加用加味补肺汤治疗,比较两组临床疗效、症状体征恢复时间及用药安全性。结果:总有效率观察组高于对照组(P<0.05),观察组X线片恢复、体温恢复、咳嗽消失、肺部啰音消失时间均短于对照组(P<0.05),治疗后观察组IgA、IgG、IgM水平均高于对照组(P<0.05)。结论:加味补肺汤联合莫沙西星治疗老年性肺炎可有效改善临床症状,提升血清免疫球蛋白水平,增强机体免疫力。 展开更多
关键词 老年性肺炎 加味补肺汤 莫沙西星 对照治疗观察
下载PDF
Quadruple therapy with moxifloxacin and bismuth for first-line treatment ofHelicobacter pylori 被引量:5
2
作者 Antonio Francesco Ciccaglione Luigina Cellini +1 位作者 Laurino Grossi Leonardo Marzio 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第32期4386-4390,共5页
AIM:To compare triple therapy vs quadruple therapy for 10 d as first-line treatment ofHelicobacter pylori(H.pylori) infection.METHODS:Consecutive H.pylori positive patients never treated in the past for this infection... AIM:To compare triple therapy vs quadruple therapy for 10 d as first-line treatment ofHelicobacter pylori(H.pylori) infection.METHODS:Consecutive H.pylori positive patients never treated in the past for this infection were randomly treated with triple therapy of pantoprazole(PAN) 20 mg bid,amoxicillin(AMO) 1 g bid and moxifloxacin(MOX) 400 mg bid for 10 d(PAM) or with quadruple therapy of PAN 20 mg bid,AMO 1 g bid,MOX 400 mg bid and bismuth subcitrate 240 mg bid for 10 d(PAMB).All patients were found positive at 13 C-Urea breath test(UBT) performed within ten days prior to the start of the study.A successful outcome was confirmed with an UBT performed 8 wk after the end of treatment.χ 2 analysis was used for statistical comparison.Per protocol(PP) and intention-to-treat(ITT) values were also calculated.RESULTS:Fifty-seven patients were enrolled in the PAM group and 50 in the PAMB group.One patient in each group did not return for further assessment.Eradication was higher in the PAMB group(negative:46 and positive:3) vs the PAM group(negative:44 and positive:12).The H.pylori eradication rate was statistically significantly higher in the PAMB group vs the PAM group,both with the PP and ITT analyses(PP:PAMB 93.8%,PAM 78.5%,P < 0.02;ITT:PAMB 92%,PAM 77.1 %,P <0.03).CONCLUSION:The addition of bismuth subcitrate can be considered a valuable adjuvant to triple therapy in those areas where H.pylori shows a high resistance to fluoroquinolones. 展开更多
关键词 Helicobacter pylori infection First-line therapy Quadruple therapy Amoxicillin Moxifloxacin Bismuth subcitrate
下载PDF
First way of enantioselective synthesis of moxifloxacin intermediate
3
《Science China(Physics,Mechanics & Astronomy)》 SCIE EI CAS 2013年第3期307-311,共5页
A new method of enantioselective synthesis of (S,S)-2,8-diazobicyclo [4.3.0] nonane was found by using (R)-2-amino-2- phenyl-ethanol as chiral induction reagent. The entire synthetic process included 8 steps which... A new method of enantioselective synthesis of (S,S)-2,8-diazobicyclo [4.3.0] nonane was found by using (R)-2-amino-2- phenyl-ethanol as chiral induction reagent. The entire synthetic process included 8 steps which were easy to operate with high yield. The purification method was only simple recrystallization or even used directly in the next step without further purifica- tion. The total yield was 29%. 展开更多
关键词 enantioselective synthesis moxifloxacin intermediate (S S)-2 8-diazobicyclo [4.3.0] nonane
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部